BlackRock Advisors’s Pfizer PFE Stock Holding History

BlackRock Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.8B	Buy	58,439,167 +8,209,319	+16%	+$251M	1.82%	4
2016 Q3	$1.61B	Sell	50,229,848 -3,805,162	-7%	-$127M	1.66%	4
2016 Q2	$1.81B	Sell	54,035,010 -714,105	-1%	-$22.8M	1.83%	3
2016 Q1	$1.54B	Buy	54,749,115 +10,489,808	+24%	+$300M	1.62%	3
2015 Q4	$1.36B	Buy	44,259,307 +529,167	+1%	+$16.6M	1.44%	4
2015 Q3	$1.3B	Buy	43,730,140 +2,282,206	+6%	+$73.2M	1.4%	6
2015 Q2	$1.32B	Sell	41,447,934 -5,571,977	-12%	-$182M	1.37%	6
2015 Q1	$1.55B	Sell	47,019,911 -2,901,803	-6%	-$92.3M	1.59%	4
2014 Q4	$1.48B	Sell	49,921,714 -2,561,243	-5%	-$73.4M	1.49%	4
2014 Q3	$1.47B	Sell	52,482,957 -6,103,815	-10%	-$171M	1.46%	4
2014 Q2	$1.65B	Sell	58,586,772 -9,856,116	-14%	-$281M	1.56%	5
2014 Q1	$2.09B	Buy	68,442,888 +930,976	+1%	+$27.8M	2.04%	2
2013 Q4	$1.96B	Sell	67,511,912 -1,966,839	-3%	-$57.2M	1.89%	2
2013 Q3	$1.89B	Sell	69,478,751 -3,293,900	-5%	-$89.6M	1.9%	2
2013 Q2	$1.93B	Buy	+72,772,651	New	+$2.01B	2.03%	2

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock Advisors's PFE Position: Q4 2016 in Review

BlackRock Advisors increased its Pfizer (PFE) stake by 16% in Q4 2016, buying an estimated $251M and bringing the position to 58,439,167 shares worth $1.8B. The position accounts for 1.82% of the portfolio, ranked #4.

BlackRock Advisors first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.09B in Q1 2014. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

BlackRock Advisors held 58,439,167 shares of Pfizer worth $1.8B as of Q4 2016.
BlackRock Advisors bought 8,209,319 Pfizer shares in Q4 2016, an estimated $251M.
Pfizer made up 1.82% of BlackRock Advisors's portfolio in Q4 2016, its #4 holding.
BlackRock Advisors first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Pfizer position peaked at $2.09B in Q1 2014.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.